Analysts' ratings for CVS Health (NYSE:CVS) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
6
4
0
0
Last 30D
1
0
0
0
0
1M Ago
0
2
3
0
0
2M Ago
0
1
1
0
0
3M Ago
0
3
0
0
0
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $79.18, with a high estimate of $94.00 and a low estimate of $58.00. This current average has decreased by 8.99% from the previous average price target of $87.00.
Decoding Analyst Ratings: A Detailed Look
The perception of CVS Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Ann Hynes
Mizuho
Lowers
Buy
$72.00
$86.00
Michael Cherny
Leerink Partners
Announces
Market Perform
$60.00
-
Sarah James
Cantor Fitzgerald
Lowers
Neutral
$58.00
$87.00
Sarah James
Cantor Fitzgerald
Maintains
Overweight
$87.00
-
Stephen Baxter
Wells Fargo
Lowers
Equal-Weight
$76.00
$83.00
Sarah James
Cantor Fitzgerald
Maintains
Overweight
$87.00
-
Jessica Tassan
Piper Sandler
Raises
Overweight
$94.00
$93.00
Andrew Mok
Barclays
Announces
Equal-Weight
$78.00
-
Michael Cherny
Leerink Partners
Announces
Outperform
$88.00
-
Sarah James
Cantor Fitzgerald
Maintains
Overweight
$87.00
-
Ben Hendrix
RBC Capital
Lowers
Outperform
$84.00
$86.00
Key Insights:
Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CVS Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.
Rating: ...Full story available on Benzinga.com
Related tickers: CVS.
Read Full Article